Key Insights on Gross Profit: GSK plc vs Dr. Reddy's Laboratories Limited

GSK vs Dr. Reddy's: A Decade of Gross Profit Trends

__timestamp	Dr. Reddy's Laboratories Limited	GSK plc
Wednesday, January 1, 2014	75801000000	15683000000
Thursday, January 1, 2015	85403000000	15070000000
Friday, January 1, 2016	92281000000	18599000000
Sunday, January 1, 2017	78356000000	19844000000
Monday, January 1, 2018	76304000000	20580000000
Tuesday, January 1, 2019	83430000000	21891000000
Wednesday, January 1, 2020	94009000000	22395000000
Friday, January 1, 2021	103077000000	22511000000
Saturday, January 1, 2022	113840000000	19770000000
Sunday, January 1, 2023	202972000000	21763000000
Monday, January 1, 2024	163607000000

Cracking the code

A Tale of Two Giants: GSK plc vs Dr. Reddy's Laboratories Limited

In the ever-evolving pharmaceutical industry, understanding the financial health of key players is crucial. This chart provides a fascinating glimpse into the gross profit trends of two industry titans: GSK plc and Dr. Reddy's Laboratories Limited, from 2014 to 2023. Over this period, Dr. Reddy's Laboratories has shown a remarkable growth trajectory, with its gross profit more than doubling, peaking at approximately 203% of its 2014 value by 2023. In contrast, GSK plc has maintained a steady performance, with its gross profit increasing by around 39% over the same period. Notably, the data for 2024 is incomplete, highlighting the dynamic nature of financial forecasting. This comparison not only underscores the competitive landscape but also reflects the strategic maneuvers each company has undertaken to bolster their market positions.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025